The New Biosimilar of Infliximab Sb2 Can Be Quantified by Ifx-Optimised Therapeutic Drug Monitoring Assays
AuthID
P-00N-VDW
P-00N-VDW
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service